Cargando…

CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma

Pancreatic adenocarcinoma (PAAD) is a common digestive tract malignant tumor with an extremely poor prognosis. The survival and prognosis may significantly improve if it is diagnosed early. Therefore, identifying biomarkers for early diagnosis is still considered a great clinical challenge in PAAD....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Chaoting, Wang, Luyang, Hu, Wanye, Tang, Lusheng, Zhang, Ping, Gao, Yan, Du, Jing, Li, Yanchun, Wang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275923/ https://www.ncbi.nlm.nih.gov/pubmed/35615982 http://dx.doi.org/10.1080/21655979.2022.2078940

Ejemplares similares

DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism
por: Du, Jing, et al.
Publicado: (2021)

TEOA Promotes Autophagic Cell Death via ROS-Mediated Inhibition of mTOR/p70S6k Signaling Pathway in Pancreatic Cancer Cells
por: Yang, Chen, et al.
Publicado: (2021)

FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis
por: Hu, Wanye, et al.
Publicado: (2021)

CDC25C as a Predictive Biomarker for Immune Checkpoint Inhibitors in Patients With Lung Adenocarcinoma
por: Zhang, Wengang, et al.
Publicado: (2022)

TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer
por: Yang, Qiannan, et al.
Publicado: (2020)

CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma
por: Wang, Feng, et al.
Publicado: (2022)

Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics
por: Kou, Yan-qi, et al.
Publicado: (2023)

Downregulation of CISD2 Has Prognostic Value in Non-Small Cell Lung Cancer and Inhibits the Tumorigenesis by Inducing Mitochondrial Dysfunction
por: Shao, Fangchun, et al.
Publicado: (2021)

CDC25C Protein Expression Correlates with Tumor Differentiation and Clinical Outcomes in Lung Adenocarcinoma
por: Stern, Esther, et al.
Publicado: (2023)

Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis
por: Ren, Xueying, et al.
Publicado: (2021)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
por: Wang, Yizhi, et al.
Publicado: (2020)

GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
por: Liu, Bo, et al.
Publicado: (2021)

AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma
por: Chen, Guo, et al.
Publicado: (2022)

Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma
por: Luan, Hong, et al.
Publicado: (2020)

Diaphanous-related formin subfamily: Novel prognostic biomarkers and tumor microenvironment regulators for pancreatic adenocarcinoma
por: Zhang, Bixi, et al.
Publicado: (2022)

Expression of cdc25A and cdc25B proteins in thyroid neoplasms
por: Ito, Y, et al.
Publicado: (2002)

Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer
por: Yu, Yiwen, et al.
Publicado: (2020)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
por: Agrawal, Shefali
Publicado: (2017)

Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma
por: Jing, Qiangan, et al.
Publicado: (2023)

Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression
por: Chang, David Z, et al.
Publicado: (2012)

Cdc25b and Cdc25c Differ Markedly in Their Properties as Initiators of Mitosis
por: Karlsson, Christina, et al.
Publicado: (1999)

PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Wang, Huanyu, et al.
Publicado: (2022)

Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
por: Wang, Zhihui, et al.
Publicado: (2010)

YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma
por: Zhao, Shilei, et al.
Publicado: (2016)

Notch3 and Hey-1 as Prognostic Biomarkers in Pancreatic Adenocarcinoma
por: Mann, Christopher D., et al.
Publicado: (2012)

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Prognostic value of biomarkers in the tumor microenvironment of pancreatic ductal adenocarcinoma
por: Mishra, Nitish K., et al.
Publicado: (2020)

Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Xu, Yongfeng, et al.
Publicado: (2022)

Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2022)

Human Cdc14A Phosphatase Modulates the G2/M Transition through Cdc25A and Cdc25B
por: Vázquez-Novelle, María D., et al.
Publicado: (2010)

Identification of CDC25C as a Potential Biomarker in Hepatocellular Carcinoma Using Bioinformatics Analysis
por: Xun, Ruifeng, et al.
Publicado: (2020)

Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma
por: Chou, Cheng-Wei, et al.
Publicado: (2021)

Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus
por: Nishioka, K, et al.
Publicado: (2001)

cdc-25.4, a Caenorhabditis elegans Ortholog of cdc25, Is Required for Male Mating Behavior
por: Oh, Sangmi, et al.
Publicado: (2016)

Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma
por: Mao, Feiyu, et al.
Publicado: (2021)

Investigating CENPW as a Novel Biomarker Correlated With the Development and Poor Prognosis of Breast Carcinoma
por: Wang, Luyang, et al.
Publicado: (2022)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma
por: Wang, Shan, et al.
Publicado: (2022)

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
por: Brunetti, Oronzo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6979c8t80vn1al6uoslqhdoa7k